10
Jun

Allergan’s board has unanimously waved off the latest bid from Valeant Pharmaceuticals and activist investor Bill Ackman, dismissing a $53 billion offer and setting the stage for proxy fight.

…read more

Source: Allergan says no to $53B as Valeant gets hostile

    

0 No comments